ArticleSurgical endoscopy2026
Characteristics of thoracoscopic anatomical lesion resection in the treatment of intralobar sequestration and congenital pulmonary airway malformation.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveIntralobar sequestration (ILS) and congenital pulmonary airway malformation (CPAM) each have their own characteristics. Therefore, there are also differences in the implementation of HuaXi-thoracoscopic anatomical lesion resection (HX-TALR). This study aims to summarize the characteristics of HX-TALR in treating ILS and CPAM.
methodsA retrospective review of clinical data was conducted for patients who underwent HX-TALR in our hospital from October 2019 to October 2024.
resultsThere were 612 patients in this study, including 158 patients with ILS and 454 patients with CPAM. The completion rate of HX-TALR in the ILS group (158/158 100%) was higher than that in the CPAM group (355/454, 78.2%). Compared with the CPAM group, the ILS group had a significantly lower average age (7.98 vs 9.13 m), mean lesion diameter (4.08 vs 4.28 cm), average operation time (61.41 vs 67.89 min), average intraoperative bleeding volume (11.99 vs 14.12 ml), and drainage tube placement time (1.17 vs 1.31 days). The proportion of single cysts with a diameter > 2 cm in the ILS group was lower than that in the CPAM group (16.46% vs 63.22%), whereas the proportion of single cysts with a diameter < 2 cm in the ILS group was significantly greater than that in the CPAM group (83.54% vs 36.78%).
conclusionHX-TALR treatment for ILS is widely applicable. The clear internal and external boundaries of the ILS make it easier to perform HX-TALR and can be selected as an early-stage case. With increasing experience, the completion rate of HX-TALR in the treatment of CPAM will also increase.
Indexed as
Identifiers
42303919What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.